Edited by Alessandro Finazzi-Agr Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
We will explore their distinct mechanisms of action, compare clinical trial results, analyze side effect profiles, evaluate cost and availability, identify who benefits most from each option, and determine when one clearly outperforms the other
But sometimes even after all our efforts, we fail to achieve the desired results
Novel delivery technologies under development may overcome current barriers to peptide administration
3 However, using Wegovy after gastric bypass is considered off-label, meaning it hasnt been specifically approved for this purpose
